Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Acq. announced
Director departure
Appointed director

SELLAS Life Sciences Group, Inc. (SLS) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/14/2021 8-K/A Quarterly results
10/24/2018 8-K/A Other Events
10/17/2018 8-K/A Quarterly results
10/05/2018 8-K/A Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
04/13/2018 8-K/A Financial Statements and Exhibits
Docs: "Letter from KPMG Audit Limited",
"Letter from KPMG Audit Limited"
04/02/2018 8-K/A Auditor change
Docs: "8-K/A",
"Letter from KPMG Audit Limited"
01/11/2018 8-K/A Completion of Acquisition or Disposition of Assets, Material Modifications to Rights of Security Holders, Changes in Control ...
08/26/2014 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/22/2012 8-K/A Form 8-K/A - Current report [Amend]
04/04/2012 8-K/A Financial Statements and Exhibits
Docs: "Unaudited pro forma condensed combined statement of expenses"
06/10/2011 8-K/A Form 8-K/A - Current report [Amend]
05/04/2011 8-K/A Form 8-K/A - Current report [Amend]
04/14/2011 8-K/A Financial Statements and Exhibits
Docs: "Consent of Lohman Company, PLLC",
"Apthera's audited financial statements for the fiscal years ended December 31, 2010 and December 31, 2009 and for the period from July 20, 2005 (date of inception) to December 31, 2010",
"RXi's unaudited pro forma condensed combined financial information"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy